Better outcomes for patients with HR+/HER2- breast cancer: spotlight on CDK4/6 inhibitors
This 1-hour interactive online education program is designed to provide medical oncologists with a practical overview of CDK4/6 inhibitors, and their current use in the Australian breast cancer management landscape.
Sign up for free and continue reading
Med CPD offers the widest range of courses and content, all accessible in one place. Click on the Sign up button and start looking after the health of your career.
MDBriefCase Group Inc.
Speakers
Dr Elgene Lim
Dr Otto Metzger
Dr Shom Goel
Duration
1 H
Accredited
-
RACP - Royal Australasian College of Physicians